Axiomer platform presentation highlighting the potential of Editing Oligonucleotides (EONs) to address liver originated disorders. Presented at the RNA Editing Gordon Research Conference on March 23, 2023 by Gerard Platenburg - ProQR Therapeutics.
… Operating and Financial Results Axiomer™ ADAR-mediated RNAediting pipeline advancing across liver and CNS programs, … In March, ProQR participated in the RNAEditingGordonResearchConference in Lucca, Italy, presenting …
Initial pipeline programs with liver delivery to address Cholestatic Diseases targeting NTCP and Cardiovascular Disease targeting B4GALT1
Development of Axiomer® RNA base editing technology platform continues across multiple therapeutic areas
Stre
